Literature DB >> 869563

Heterozygote advantage.

J H Edwards.   

Abstract

Mesh：

Year:  1977        PMID： 869563      PMCID： PMC1544554          DOI： 10.1136/adc.52.5.343

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  2 in total

1.  Oyster ciliary inhibition by cystic fibrosis factor.

Authors:  B H Bowman; L H Lockhart; M L McCombs
Journal:  Science       Date:  1969-04-18       Impact factor: 47.728

2.  Abnormal serum factor in patients with cystic fibrosis of the pancreas.

Authors:  A Spock; H M Heick; H Cress; W S Logan
Journal:  Pediatr Res       Date:  1967-05       Impact factor: 3.756
  2 in total
  3 in total

1.  Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene.

Authors:  G R Cutting; S E Antonarakis; K H Buetow; L M Kasch; B J Rosenstein; H H Kazazian
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

2.  A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers.

Authors:  L B Jorde; G M Lathrop
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

3.  Genetic Polymorphisms of TLR4 and MICA are Associated with Severity of Trachoma Disease in Tanzania.

Authors:  Muneer Abbas; Noureddine Berka; Mozna Khraiwesh; Ali Ramadan; Victor Apprey; Paulette Furbert-Harris; Thomas Quinn; Hassan Brim; Georgia Dunston
Journal:  Autoimmune Infect Dis       Date:  2016-06-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.